{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:05:17Z","timestamp":1770815117670,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejves.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Vascular and Endovascular Surgery"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.ejvs.2015.09.010","type":"journal-article","created":{"date-parts":[[2015,10,26]],"date-time":"2015-10-26T21:48:48Z","timestamp":1445896128000},"page":"83-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Quality of Life After Treatment with Autologous Bone Marrow Derived Cells in No Option Severe Limb Ischemia"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8621-4477","authenticated-orcid":false,"given":"S.M.O.","family":"Peeters Weem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Teraa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.M.","family":"den Ruijter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.J.","family":"de Borst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.C.","family":"Verhaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.L.","family":"Moll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ejvs.2015.09.010_bib1","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jvs.2010.04.057","article-title":"Quality of life in patients with no option critical limb ischemia underlines the need for new effective treatment","volume":"52","author":"Sprengers","year":"2010","journal-title":"J\u00a0Vasc Surg"},{"issue":"4","key":"10.1016\/j.ejvs.2015.09.010_bib2","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.jvs.2012.02.069","article-title":"Cost-effectiveness in the contemporary management of critical limb ischemia with tissue loss","volume":"56","author":"Barshes","year":"2012","journal-title":"J\u00a0Vasc Surg"},{"issue":"Suppl. S","key":"10.1016\/j.ejvs.2015.09.010_bib3","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-society consensus for the management of peripheral arterial disease (TASC II)","volume":"45","author":"Norgren","year":"2007","journal-title":"J\u00a0Vasc Surg"},{"issue":"6","key":"10.1016\/j.ejvs.2015.09.010_bib4","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/SLA.0b013e3182854cf1","article-title":"autologous bone marrow derived cell therapy in patients with critical limb ischemia: a meta-analysis of randomized controlled clinical trials","volume":"258","author":"Teraa","year":"2013","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.ejvs.2015.09.010_bib5","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jvs.2011.10.089","article-title":"Improved amputation free survival in unreconstructable critical limb ischemia and its implications for clinical trial design and quality measurement","volume":"55","author":"Benoit","year":"2012","journal-title":"J\u00a0Vasc Surg"},{"issue":"1","key":"10.1016\/j.ejvs.2015.09.010_bib6","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00005650-199401000-00004","article-title":"The MOS 36-Item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups","volume":"32","author":"McHorney","year":"1994","journal-title":"Med Care"},{"key":"10.1016\/j.ejvs.2015.09.010_bib7","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1161\/CIRCULATIONAHA.114.012913","article-title":"Effect of repetitive intra-arterial infusion of bone marrow mononuclear cells in patients with no option limb ischemia: the randomized, double blind, placebo-controlled JUVENTAS Trial","volume":"131","author":"Teraa","year":"2015","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ejvs.2015.09.010_bib8","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.jvs.2010.02.020","article-title":"Rationale and design of the JUVENTAS trial for repeated intra-arterial infusion of autologous bone marrow derived mononuclear cells in patients with critical limb ischemia","volume":"51","author":"Sprengers","year":"2010","journal-title":"J\u00a0Vasc Surg"},{"issue":"11","key":"10.1016\/j.ejvs.2015.09.010_bib9","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0895-4356(98)00097-3","article-title":"Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations","volume":"51","author":"Aaronson","year":"1998","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"3","key":"10.1016\/j.ejvs.2015.09.010_bib10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol\u2014a new facility for the measurement of health related quality of life","volume":"16","author":"Euroqol group","year":"1990","journal-title":"Health Policy (New York)"},{"key":"10.1016\/j.ejvs.2015.09.010_bib11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0895-4356(00)00305-X","article-title":"Are randomized clinical trials good for us (in the short term)? Evidence for a \u201ctrial effect\u201d","volume":"54","author":"Braunholtz","year":"2001","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"5","key":"10.1016\/j.ejvs.2015.09.010_bib12","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2307\/2094540","article-title":"The Hawthorne experiments: first statistical interpretation","volume":"43","author":"Franke","year":"1978","journal-title":"Am Sociol Rev"},{"key":"10.1016\/j.ejvs.2015.09.010_bib13","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/sim.3180","article-title":"Placebo effect-adjusted assessment of quality of life in placebo-controlled clinical trials","volume":"27","author":"Eickhoff","year":"2008","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.ejvs.2015.09.010_bib14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/nau.20083","article-title":"\u201cUnblinding\u201d in randomized controlled drug trials for urinary incontinence: implications for assessing outcomes when adverse effects are evident","volume":"24","author":"DuBeau","year":"2005","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"10.1016\/j.ejvs.2015.09.010_bib15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0895-4356(95)00540-4","article-title":"Nonspecific effects in longitudinal studies: impact on quality of life measures","volume":"49","author":"Bouchet","year":"1996","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"8","key":"10.1016\/j.ejvs.2015.09.010_bib16","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1007\/s11136-014-0669-9","article-title":"Results from several population studies show that recommended scoring methods of the SF-36 and the SF-12 may lead to incorrect conclusions and subsequent health decisions","volume":"23","author":"Tucker","year":"2014","journal-title":"Qual Life Res"},{"issue":"5","key":"10.1016\/j.ejvs.2015.09.010_bib17","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1007\/s11136-013-0586-3","article-title":"A\u00a0comparison of SF-36 summary measures of physical and mental health for women across the life course","volume":"23","author":"Mishra","year":"2014","journal-title":"Qual Life Res"},{"issue":"1","key":"10.1016\/j.ejvs.2015.09.010_bib18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11136-008-9423-5","article-title":"Comparison between exploratory factor-analytic and SEM-based approaches to constructing SF-36 summary scores","volume":"18","author":"Anagnostopoulos","year":"2009","journal-title":"Qual Life Res"},{"issue":"5","key":"10.1016\/j.ejvs.2015.09.010_bib19","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1023\/A:1012552211996","article-title":"Do SF-36 summary component scores accurately summarize subscale scores?","volume":"10","author":"Taft","year":"2001","journal-title":"Qual Life Res"},{"issue":"3","key":"10.1016\/j.ejvs.2015.09.010_bib20","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s11136-008-9310-0","article-title":"The SF-36 scales are not accurately summarised by independent physical and mental component scores","volume":"17","author":"Hann","year":"2008","journal-title":"Qual Life Res"}],"container-title":["European Journal of Vascular and Endovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588415006851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588415006851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T11:44:10Z","timestamp":1761047050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078588415006851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S1078588415006851"],"URL":"https:\/\/doi.org\/10.1016\/j.ejvs.2015.09.010","relation":{},"ISSN":["1078-5884"],"issn-type":[{"value":"1078-5884","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality of Life After Treatment with Autologous Bone Marrow Derived Cells in No Option Severe Limb Ischemia","name":"articletitle","label":"Article Title"},{"value":"European Journal of Vascular and Endovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejvs.2015.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}